Clinical study of leflunomide in the treatment of patients with active rheumatoid arthritis
- VernacularTitle:来氟米特治疗类风湿关节炎的临床研究
- Author:
Xiangpei LI
;
Xiaomei LI
;
Guosheng WANG
;
Shuguang SHAN
;
Long QIAN
;
- Publication Type:Journal Article
- Keywords:
arthritis/rheumatoid;
leflunomide;
methotrexate
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2000;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).The adverse reaction rate was 14.0% (7 case) in the treated group and 15.6%(7 cases) in the controlled group. There was no significance difference between the two groups (P=0.83). But the adverse reactions were more tolerable in LEF group than in MTX group. Conclusion This study suggests that LEF is an effective and more safe drug for active rheumatoid arthritis in our country.
